Experts released clinical guidance on anticoagulant use in children at risk of venous thromboembolism (VTE), offering ...

In recent years, efforts to interrogate established medical practices rooted in sometimes decades-old dogma have led to ...

During a live event, Carol Ann Huff, MD, and participants discussed real-world evidence and personal experiences with talquetamab in relapsed/refractory multiple myeloma.

Invivyd, Inc. is a Sell as recent trial expansion signals weaker-than-hoped efficacy and introduces further delays for ...

Without timely and appropriate treatment, hepatitis B virus (HBV) infection can progress to liver fibrosis, cirrhosis or hepatocellular carcinoma (HCC), contributing significantly to global ...

This is an example of successful public health,” Dr. Jonathan Mermin, who led the CDC’s National Center for HIV, Viral ...

Preventive measures have been stepped up since April 1. Read more at straitstimes.com. Read more at straitstimes.com.

Hemlibra worked better than immune tolerance induction to control bleeding in children with severe hemophilia A with inhibitors, per a study.

Detailed price information for Chugai Pharmaceutical (CHGCF) from The Globe and Mail including charting and trades.

Five vaccines in development for HIV, tuberculosis, cancer, influenza, and coronaviruses could transform global health.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today released "Still Here," a social media video campaign designed to spark crucial ...

An increasing number of U.S. states have passed laws that allow health care providers – including doctors, nurses and pharmacists – to refuse to treat patients based on their personal or religious ...